Literature DB >> 6703432

A survey of Washington state freestanding emergency centers.

D J Schaffer.   

Abstract

A survey was conducted of the known FECs in the state of Washington in 1982 to assess facility organization and staffing patterns, equipment available, types of services offered, overall morbidity, and community acceptance. The 15 facilities responding saw an average of 25.6 patients in a 12.5-hour day, seven days per week. None of the facilities encouraged or accepted critical ambulance cases, and only one accepted non-critical transport patients. Essentially all have ACLS-trained physicians and resuscitation equipment, but only 0.003% of the total patient census required this intervention. A majority of the facilities utilized the word "emergency" in their title, but none indicated that this caused confusion for their patients. By self-assessment, public acceptance has been overwhelmingly positive, while primary care and hospital emergency physicians have been cool to the concept.

Entities:  

Mesh:

Year:  1984        PMID: 6703432     DOI: 10.1016/s0196-0644(84)80474-6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  4 in total

Review 1.  Walk-in centres in primary care: a review of the international literature.

Authors:  Chris Salisbury; James Munro
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

2.  Ontario walk-in clinics: a preliminary descriptive study.

Authors:  G B Miller; Z Mah; S Nantes; W Bryant; T Kayler; K McKinnon
Journal:  Can Fam Physician       Date:  1989-10       Impact factor: 3.275

3.  Walk-in clinics in Ontario. An atmosphere of tension.

Authors:  Judith Belle Brown; L Michelle Sangster Bouck; Truls Østbye; Janet M Barnsley; Maria Mathews; Gina Ogilvie
Journal:  Can Fam Physician       Date:  2002-03       Impact factor: 3.275

4.  Walk-in Clinics and Primary Care: Review of the Literature.

Authors:  G B Miller; S Nantes
Journal:  Can Fam Physician       Date:  1989-10       Impact factor: 3.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.